Full Text View
Tabular View
Study Results
Related Studies
Complementary and Alternative Medicine for Urological Symptoms(CAMUS)
This study has been completed.
Study NCT00603304   Information provided by University of Alabama at Birmingham

First Received on December 20, 2007.   Last Updated on September 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Urological
Interventions listed in this trial
Saw Palmetto - first 24 weeks
Placebo - first 24 weeks
Saw Palmetto - weeks 24 - 48
Placebo - weeks 24 - 48
Saw Palmetto - weeks 48 - 72
Placebo - weeks 48 - 72
Additional drug interventions recognized in this trial
Permixon
More general drug interventions related to this trial
Androgen Antagonists
Estrogen Antagonists
Estrogen Receptor Modulators
Hormone Antagonists
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
University of Alabama at Birmingham
Office of Dietary Supplements (ODS)
National Center for Complementary and Alternative Medicine (NCCAM)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Cornell University
New York University
Kaiser Permanente
Northwestern University
Queen's University
University of Colorado, Denver
University of Iowa
University of Maryland
University of Texas
Washington University School of Medicine
Yale University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services